Section 841(a)(1): Federal Drug Charges and Sentencing

21 U.S.C. 841(a)(1) prohibits knowingly or intentionally manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense a controlled substance, except as authorized. Simple possession and possession with intent are different allegations. [1]

Identify the act and mental state

The government must prove the charged conduct and required knowledge. Actual or constructive possession, a transfer, and intent to distribute depend on the evidence. Quantity, packaging, communications, and other circumstances can be relevant, but no single informal label resolves the case.

Penalties come from subsection (b)

The drug, quantity, prior qualifying convictions, and specified injury or death findings can change the statutory range. Some tiers have mandatory minimums. The applicable range should be identified from the charged and proven facts rather than a generic claim that every federal drug charge carries the same sentence. [1]

Scientific evidence deserves scrutiny

Review laboratory identification, weight calculations, sampling, chain of custody, and the limits of expert testimony. NIST’s seized-drug testimony guide addresses appropriate communication of analytical findings and limitations. [2]

For example, the gross weight of packaging is not automatically the legally relevant drug quantity. Mixture, substance, and purity provisions must be read for the specific drug and penalty tier.

Distinguish range calculations from sentencing discretion

First determine the legally applicable statutory range, then examine guidelines, adjustments, departures, and any authorized relief from a mandatory minimum. A low recommended guideline sentence does not itself eliminate a statutory minimum. Conversely, merely identifying a minimum does not answer whether a legally available exception applies. Ask counsel to explain the drug identity, quantity rule, charged enhancement, and findings necessary for each step. Medical authorization can also be relevant only within its lawful scope; it does not make every distribution or dispensing activity authorized. A useful case summary separates the alleged act, scientific identification, statutory penalty tier, and remaining sentencing issues rather than presenting one unexplained prison estimate. [1]

Preserve search records, lab reports, and communications for counsel. See distribution to a person under 21 and drug-conspiracy charges for enhancements and theories that require additional analysis.

Primary sources

  1. 21 U.S.C. 841
  2. OSAC 2022-S-0013 Standard Guide for Testimony in Seized Drugs Analysis Version 2.1

Sources checked: October 31, 2026.